All articles tagged with #pazdur
Former FDA oncology chief Richard Pazdur, who left last month, told STAT at the JPMorgan Healthcare Conference that politicization is eroding the FDA’s firewall between political appointees and drug reviewers and that there’s insufficient transparency around a new expedited-review voucher program.
Former FDA regulator Richard Pazdur, who recently left the agency, says political interference and a new voucher program for accelerated drug reviews have breached the firewall between politics and reviewers, with opaque meetings and limited staff access raising concerns about transparency and independence in drug approvals.
The FDA's top drug regulator, Dr. Pazdur, has submitted his resignation after 26 years, raising concerns about leadership stability and the future of drug regulation, amid ongoing debates over the agency's programs and political influence.